Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 27:14:4945-4954.
doi: 10.2147/JIR.S327597. eCollection 2021.

Association Between Micronutrient Concentrations and Human Epididymis Protein 4

Affiliations

Association Between Micronutrient Concentrations and Human Epididymis Protein 4

Zhu Wei Lim et al. J Inflamm Res. .

Abstract

Background: Human epididymis protein 4 (HE4) has been frequently used to study in many malignant tumors, while serum nutritional markers are used to determine a person's health status. However, the link between serum micronutrient concentrations and HE4 has not yet been clarified.

Methods: A total of 2464 eligible female participants and serum concentrations of nutritional biomarkers were chosen from the National Health and Nutrition Examination Surveys (NHANES) 2001-2002. For statistical analysis, we used the χ 2 test, multivariable linear regression, and analysis of variance. Adjusted models were used, and the concentrations of serum nutritional biomarkers were divided into quartiles.

Results: The mean age of the participants was 48.07 years. Among twelve micronutrients, five were negatively associated with HE4 in models 1, 2 and 3. Only α-carotene, trans-β-carotene, cis-β-carotene, trans-lycopene and retinol were associated with HE4, with beta coefficients of -0.102, -0.027, -0.506, -0.131 and -0.054, respectively. After performing quartile-based analysis, statistical significance was only found for serum α-carotene, trans-lycopene, and retinol in the three models. In model 3, the beta coefficients [95% confidence intervals (CIs)] of the fourth quartiles compared to the first quartiles for α-carotene, trans-lycopene, and retinol were -3.390 (-5.053, -1.727), -4.036 (-5.722, -2.351) and -4.146 (-5.899, -2.393), respectively. Serum concentrations of these three nutritional biomarkers were inversely related to serum HE4 concentration (p trend <0.001).

Conclusion: HE4 is a useful and novel biomarker that can be used with many diseases, especially ovarian cancer. Three of our selected micronutrients were inversely associated with HE4 concentration. Supplement of micronutrients may reduce the levels of HE4 and the subsequent of ovarian cancer's risk. Therefore, a formula that correlates HE4 with nutritional biomarkers needs to be established before use in clinical applications.

Keywords: carotenoids; human epididymis protein 4; vitamin A; vitamin E.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1
Flow chart.
Figure 2
Figure 2
Associations between serum nutritional biomarkers and human epididymis protein 4.

References

    1. Barani M, Bilal M, Sabir F, Rahdar A, Kyzas GZ. Nanotechnology in ovarian cancer: diagnosis and treatment. Life Sci. 2020;266:118914. - PubMed
    1. Funston G, Hamilton W, Abel G, Crosbie EJ, Rous B, Walter FM. The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: a population-based cohort study. PLoS Med. 2020;17:e1003295. doi:10.1371/journal.pmed.1003295 - DOI - PMC - PubMed
    1. Nolen BM, Lokshin AE. Protein biomarkers of ovarian cancer: the forest and the trees. Future Oncol. 2012;8:55–71. doi:10.2217/fon.11.135 - DOI - PMC - PubMed
    1. Hertlein L, Stieber P, Kirschenhofer A, et al. Human epididymis protein 4 (HE4) in benign and malignant diseases. Clin Chem Lab Med. 2012;50:2181–2188. doi:10.1515/cclm-2012-0097 - DOI - PubMed
    1. Saini RK, Keum YS, Daglia M, Rengasamy KR. Dietary carotenoids in cancer chemoprevention and chemotherapy: a review of emerging evidence. Pharmacol Res. 2020;157:104830. doi:10.1016/j.phrs.2020.104830 - DOI - PubMed